Skip to main content
Swing Capital

Biofil Chemicals & Pharmaceuticals Ltd

NSE: BIOFILCHEM BSE: 524396

Incorporated in 1993, Biofil Chemicals and Pharmaceuticals Ltd deals in Pharmaceuticals and Chemicals products.[1]

₹32.3
52W: ₹25.6 — ₹57.2
PE 19 · Book ₹13.1 · +147% vs book
Market Cap₹52.5 Cr
Stock P/E19Price to Earnings
ROCE4.12%Return on Capital
ROE3.03%Return on Equity
Div. Yield0%Face Value ₹10

Strengths

  • +Company has reduced debt.
  • +Company is almost debt free.

Weaknesses

  • −Stock is trading at 2.49 times its book value
  • −Though the company is reporting repeated profits, it is not paying out dividend
  • −The company has delivered a poor sales growth of 2.38% over past five years.
  • −Company has a low return on equity of 3.43% over last 3 years.
  • −Earnings include an other income of Rs.3.21 Cr.
  • −Company has high debtors of 419 days.

Shareholding Pattern

Promoters46.79%
FIIs0%
DIIs0.08%
Public53.12%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters46.82%46.82%46.82%46.82%46.82%46.79%▼0.046.79%46.79%
FIIs0%0%0%0%0%0%0%0%
DIIs0.08%0.08%0.08%0.08%0.08%0.08%0.08%0.08%
Public53.11%53.1%▼0.053.11%▲0.053.11%53.1%▼0.053.12%▲0.053.13%▲0.053.12%▼0.0

Financial Statements

MetricSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Sales17.375.0315.28.442.4114.28.356.4313.540.86
Expenses17.134.8415.248.132.2913.898.246.4213.420.77
Operating Profit0.240.19-0.040.310.120.310.110.010.120.09
OPM %1.38%3.78%-0.26%3.67%4.98%2.18%1.32%0.16%0.89%10.47%
Net Profit0.120.090.250.170.020.160.22.410.080.08
EPS ₹0.070.060.150.10.010.10.121.480.050.05

AI Insights

Revenue Trend

TTM revenue at ₹29.18Cr, down 12.6% YoY. OPM at 1.13%.

Debt Position

Borrowings at ₹0.02Cr. Debt-to-equity ratio: 0.00x. Healthy balance sheet.

Institutional Flow

DIIs: 0.08% (+0.00pp change). FIIs: 0% (+0.00pp change). Promoters hold 46.79%.

Margin & Efficiency

ROCE declining from 7.66% (Mar 2014) to 4.12% (Mar 2025). Working capital days: 114.09.

Valuation

PE 19x with 4.12% ROCE. Price is 147% above book value of ₹13.1. Dividend yield: 0%.

Recent Announcements